S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis.
about
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next StepNonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment optionsNonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective.Pathogenesis of liver cirrhosis.Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy.Heat shock protein 70 promotes lipogenesis in HepG2 cells.
P2860
S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
S-nitroso-N-acetylcysteine att ...... nonalcoholic steatohepatitis.
@en
S-nitroso-N-acetylcysteine att ...... nonalcoholic steatohepatitis.
@nl
type
label
S-nitroso-N-acetylcysteine att ...... nonalcoholic steatohepatitis.
@en
S-nitroso-N-acetylcysteine att ...... nonalcoholic steatohepatitis.
@nl
prefLabel
S-nitroso-N-acetylcysteine att ...... nonalcoholic steatohepatitis.
@en
S-nitroso-N-acetylcysteine att ...... nonalcoholic steatohepatitis.
@nl
P2093
P2860
P50
P356
P1476
S-nitroso-N-acetylcysteine att ...... l nonalcoholic steatohepatitis
@en
P2093
Claudia P M S de Oliveira
Fabiana R Lima
Fabíola Rabelo
Flair J Carrilho
Isabel V A Pereira
José T Stefano
Marcelo G de Oliveira
Venâncio A Ferreira Alves
P2860
P304
P356
10.2147/DDDT.S43930
P407
P577
2013-06-28T00:00:00Z